DUTKO WORLDWIDE, LLC for GENZYME
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
Monitor federal legislation related to health care IP issues and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (bill number has not yet been assigned), Pathway for Biosimilars Act (H.R. 1548), Physician Payments Sunshine Act of 2009 (S301) & American Recovery and Reinvestment Act of 2009 (HR1) as it relates to comparative effectiveness research funding. Health Care Reform Legislation (to date no specific bills have been introduced). Pharmaceutical import safety legislation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CECIL SWAMIDOSS New | 2008). |
| DARREN WILLCOX | — |
Health Issues HCR
Monitor federal legislation related to Medicare and other health care issues and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (bill number has not yet been assigned), Pathway for Biosimilars Act (H.R. 1548), Physician Payments Sunshine Act of 2009 (S301) & American Recovery and Reinvestment Act of 2009 (HR1) as it relates to comparative effectiveness research funding. Health Care Reform Legislation (to date no specific bills have been introduced). Pharmaceutical import safety legislation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CECIL SWAMIDOSS New | 2008). |
| DARREN WILLCOX | — |
Medicare/Medicaid MMM
Monitor federal legislation related to Medicare and other health care issues and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (bill number has not yet been assigned), Pathway for Biosimilars Act (H.R. 1548), Physician Payments Sunshine Act of 2009 (S301) & American Recovery and Reinvestment Act of 2009 (HR1) as it relates to comparative effectiveness research funding. Health Care Reform Legislation (to date no specific bills have been introduced). Pharmaceutical import safety legislation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CECIL SWAMIDOSS New | 2008). |
| DARREN WILLCOX | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.